AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2010

Oct 28, 2010

34023_dirs_2010-10-28_2f6c56cd-5c35-4039-b732-8b61ec632821.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-10-26

Reporting Person: Valentine Karen (VP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-10-26	Common Stock	A	2500	$0.98	Acquired	58991	Direct
2010-10-27	Common Stock	S	2500	$0.98	Disposed	56491	Direct

Footnotes

F1: Represents settlement of restricted stock awarded on January 26, 2010.

F2: Represents the sale of shares obtained from the vesting of the restricted stock awarded on January 26, 2010. This sale was made through a 10b5-1 trading plan.